Researchers, physicians, families and affected patients view Duchenne muscular dystrophy (DMD) as a neuromuscular condition. Children are diagnosed during the first years of life because they have ...
Solid Biosciences reported recent positive data in developing their gene therapy candidate SGT-003. The phase 1/2 INSPIRE ...
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
Three Washington, D.C., healthcare policy experts and the former chief of staff of HHS dive into the healthcare politics and policies of the new administration: RFK Jr.’s confirmation hearings; the ...
Medicaid is a needs-based program, but the misconception that it is a program solely for poor people has made it a target for ...
Blue Cross Blue Shield of Michigan said it is evaluating any potential updates to the coverage process for Darzalex Faspro ...
At what was supposed to be a hearing to discuss PBM reform, some in Congress veered off into discussions about Medicaid and ...
But major cuts to federal for Medicaid are a likely outcome of the $1.5-$2 trillion in spending cuts over the next 10 years ...
Unlike some other spending cuts, Medicaid cuts will have direct impact on people who voted for Republicans in November 2024, ...
Simlandi and adalimumab-adaz have been with on formulary, along with Humira, beginning Jan. 1, 2025, Arpit Patel, Pharm.D., ...
The FDA has accepted the biologics licensing application (BLA) resubmission for odronextamab, a potential treatment for ...
This once-daily topical treatment is the latest phosphodiesterase-4 (PDE4) inhibitor designed for mild to moderate atopic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results